117 related articles for article (PubMed ID: 24835529)
21. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
[TBL] [Abstract][Full Text] [Related]
22. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer.
Huang F; Wang BR; Wu YQ; Wang FC; Zhang J; Wang YG
World J Gastroenterol; 2016 Sep; 22(35):7999-8009. PubMed ID: 27672294
[TBL] [Abstract][Full Text] [Related]
23. [Measles virus: a future therapeutic agent in oncology?].
Touchefeu Y; Schick U; Harrington KJ
Med Sci (Paris); 2012 Apr; 28(4):388-94. PubMed ID: 22549866
[TBL] [Abstract][Full Text] [Related]
24. Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses.
Weiland T; Lampe J; Essmann F; Venturelli S; Berger A; Bossow S; Berchtold S; Schulze-Osthoff K; Lauer UM; Bitzer M
Int J Cancer; 2014 Jan; 134(1):235-43. PubMed ID: 23797800
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic potential of oncolytic measles virus: promises and challenges.
Galanis E
Clin Pharmacol Ther; 2010 Nov; 88(5):620-5. PubMed ID: 20881957
[TBL] [Abstract][Full Text] [Related]
26. Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.
Bach P; Abel T; Hoffmann C; Gal Z; Braun G; Voelker I; Ball CR; Johnston IC; Lauer UM; Herold-Mende C; Mühlebach MD; Glimm H; Buchholz CJ
Cancer Res; 2013 Jan; 73(2):865-74. PubMed ID: 23293278
[TBL] [Abstract][Full Text] [Related]
27. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW
Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872
[TBL] [Abstract][Full Text] [Related]
28. Potential and clinical translation of oncolytic measles viruses.
Robinson S; Galanis E
Expert Opin Biol Ther; 2017 Mar; 17(3):353-363. PubMed ID: 28129716
[TBL] [Abstract][Full Text] [Related]
29. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
[TBL] [Abstract][Full Text] [Related]
30. Mathematical modeling of cancer radiovirotherapy.
Dingli D; Cascino MD; Josić K; Russell SJ; Bajzer Z
Math Biosci; 2006 Jan; 199(1):55-78. PubMed ID: 16376950
[TBL] [Abstract][Full Text] [Related]
31. Personalized Oncolytic Therapy: The Next Step Toward the Successful Clinical Application of Vaccine-Strain Measles Viruses for Cancer Therapy?
Peikert T
J Thorac Oncol; 2020 May; 15(5):689-691. PubMed ID: 32340675
[No Abstract] [Full Text] [Related]
32. Dynamics of multiple myeloma tumor therapy with a recombinant measles virus.
Dingli D; Offord C; Myers R; Peng KW; Carr TW; Josic K; Russell SJ; Bajzer Z
Cancer Gene Ther; 2009 Dec; 16(12):873-82. PubMed ID: 19498461
[TBL] [Abstract][Full Text] [Related]
33. Scientists are harnessing viruses to treat tumours.
Brown C
Nature; 2020 Nov; 587(7835):S60-S62. PubMed ID: 33239805
[No Abstract] [Full Text] [Related]
34. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM
Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138
[TBL] [Abstract][Full Text] [Related]
35. United virus: the oncolytic tag-team against cancer!
Le Boeuf F; Bell JC
Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
[TBL] [Abstract][Full Text] [Related]
36. Combined expression of miR-34a and Smac mediated by oncolytic vaccinia virus synergistically promote anti-tumor effects in Multiple Myeloma.
Lei W; Wang S; Yang C; Huang X; Chen Z; He W; Shen J; Liu X; Qian W
Sci Rep; 2016 Aug; 6():32174. PubMed ID: 27552933
[TBL] [Abstract][Full Text] [Related]
37. Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers.
Liu C; Russell SJ; Peng KW
Mol Ther; 2010 Jun; 18(6):1155-64. PubMed ID: 20234340
[TBL] [Abstract][Full Text] [Related]
38. Translational research in oncolytic measles virotherapy: early discoveries and future steps.
Msaouel P; Opyrchal M; Galanis E
Future Microbiol; 2011 Feb; 6(2):125-8. PubMed ID: 21366411
[No Abstract] [Full Text] [Related]
39. Viral Therapy Gets Personal: A Potential Gene Signature to Predict Susceptibility to Measles Virus Oncolysis.
Forsyth PA; Abate-Daga D
J Natl Cancer Inst; 2018 Oct; 110(10):1139-1140. PubMed ID: 29757401
[No Abstract] [Full Text] [Related]
40. Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors.
Deyle DR; Escobar DZ; Peng KW; Babovic-Vuksanovic D
Gene; 2015 Jul; 565(1):140-5. PubMed ID: 25843626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]